These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15139350)

  • 21. Medical journal cites misleading drug research.
    Grady D
    N Y Times Web; 1999 Nov; ():A18. PubMed ID: 11648133
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on: developing good scientific publishing practices: one pharmaceutical company's perspective.
    Norris RA
    Curr Med Res Opin; 2010 Jul; 26(7):1675-6. PubMed ID: 20450261
    [No Abstract]   [Full Text] [Related]  

  • 23. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
    Liss H
    Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive reasons for publishing negative findings.
    Connor JT
    Am J Gastroenterol; 2008 Sep; 103(9):2181-3. PubMed ID: 18671812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ghostwriting in medical literature.
    Int J Occup Environ Health; 2011; 17(2):168-77. PubMed ID: 21618949
    [No Abstract]   [Full Text] [Related]  

  • 27. Impugning the integrity of medical science: the adverse effects of industry influence.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
    [No Abstract]   [Full Text] [Related]  

  • 28. The whole truth: drug companies must tell us all they know about the medicines we take.
    New Sci; 2004 May 1-7; 182(2445):3. PubMed ID: 15278970
    [No Abstract]   [Full Text] [Related]  

  • 29. Trials and tribulations: new pressure on drug companies to reveal all about their clinical tests.
    Economist; 2004 Jun; 371(8380):62-3. PubMed ID: 15457617
    [No Abstract]   [Full Text] [Related]  

  • 30. Conflict of interest.
    Headley E; Moulton OC
    Trends Endocrinol Metab; 2006 Dec; 17(10):379. PubMed ID: 17055288
    [No Abstract]   [Full Text] [Related]  

  • 31. Corporate versus public interests: community responsibility to defend scientific integrity.
    Egilman DS; Druar NM
    Int J Occup Environ Health; 2011; 17(2):181-5. PubMed ID: 21618951
    [No Abstract]   [Full Text] [Related]  

  • 32. Module six: special issues.
    Schneider B; Schüklenk U
    Dev World Bioeth; 2005 Mar; 5(1):92-108. PubMed ID: 15748180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug companies, doctors and disclosures.
    Tuorto S; Chan MK; Adusumilli PS
    Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 35. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary: What's wrong with ghostwriting?
    Elliott C; Landa AS
    Bioethics; 2010 Jul; 24(6):284-6. PubMed ID: 20497172
    [No Abstract]   [Full Text] [Related]  

  • 37. Promoting transparency in pharmaceutical industry-sponsored research.
    Ross JS; Gross CP; Krumholz HM
    Am J Public Health; 2012 Jan; 102(1):72-80. PubMed ID: 22095335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Regulatory Toxicology and Pharmacology.
    Merkel-Sobotta E
    Int J Occup Environ Health; 2003; 9(4):390; author reply 390-1. PubMed ID: 14664494
    [No Abstract]   [Full Text] [Related]  

  • 39. In defense of full disclosure.
    Wilson S
    JAAPA; 2006 Jun; 19(6):48-9. PubMed ID: 16789358
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmaceutical companies and ophthalmic research.
    Liesegang TJ; Schachat AP; Albert DA
    Ophthalmology; 2005 Mar; 112(3):363-5. PubMed ID: 15745760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.